Authors:
LIBERATI AM
VERDUCCI N
BETTI AR
ALSHARJABY N
ROMANO R
GENUA A
STIVAKTAKI A
TROTTINI M
SCHIPPA M
METTIVIER V
DONTI E
Citation: Am. Liberati et al., IFN-ALPHA THERAPY FOR CHRONIC MYELOID-LEUKEMIA - A SINGLE-CENTER EXPERIENCE, British Journal of Haematology, 102(1), 1998, pp. 187-187
Authors:
LIBERATI AM
TROTTINI M
GENUA A
ROMANO R
STIVAKTAKI A
SCHIPPA M
BETTI AR
ALSHARJABY N
METTIVIER V
MOSCHINI TO
NICOLI P
MESSINA S
PALUMBO B
PALUMBO R
Citation: Am. Liberati et al., EVALUATION OF RESPONSE TO THERAPY WITH GA-67 SCINTIGRAPHY, CT SCAN AND MAGNETIC-RESONANCE IN MALIGNANT-LYMPHOMAS, British Journal of Haematology, 102(1), 1998, pp. 246-246
Authors:
SCHIAVONE EM
METTIVIER V
DEROSA L
FERRARA F
CIMINO R
VACCA C
FINIZIO O
BENE L
SPADA OA
MOLINARI AM
NOLA E
Citation: Em. Schiavone et al., A DISTINCTIVE MEMBRANE PHENOTYPE MARKS BLASTS FROM MYELOID BLASTIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA, Blood, 90(10), 1997, pp. 2237-2237
Authors:
CIMINO R
RAMETTA V
MATERA C
MELE G
METTIVIER V
FERRARA F
Citation: R. Cimino et al., RECOMBINANT INTERFERON-ALPHA-2B IN THE TREATMENT OF POLYCYTHEMIA-VERA, American journal of hematology, 44(3), 1993, pp. 155-157